Hexosaminidase isoenzyme profiles in leukemic cells. 1983

T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui

The isoenzyme profiles of hexosaminidase in leukemic cells from 39 patients were examined with DEAE-Sephadex chromatography. There was a clear difference in the isoenzyme composition between normal lymphocytes and granulocytes. In acute non-T/non-B lymphocytic leukemia (ALL) a characteristic alteration was found in the intermediate forms of hexosaminidase (Hex I), which was significantly higher than those of normal lymphocytes (p less than 0.001). Subtypes of Hex I (Hex i1-i4) and the heterogeneity of their abnormal expression in ALL was demonstrated. There was no type-specific alteration of the isoenzyme profiles in T-cell leukemia. Leukemic cells of acute myelocytic leukemia (AML) had significantly higher Hex P component than granulocytes (p less than 0.01) and ALL cells (p less than 0.01). The increase of Hex P was evident in childhood AML. There was a significant difference in Hex P level between childhood AML and adult myelo(mono)genous leukemia (p less than 0.001). Chronic myelo(mono)genous leukemia showed similar isoenzyme compositions to normal granulocytes. The isoenzyme profiles in acute undifferentiated leukemia differed from those in other types of leukemia. Isoenzyme analysis might be useful for probing the nature and the intrinsic biochemical abnormality of leukemic cells.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002852 Chromatography, Ion Exchange Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. Chromatography, Ion-Exchange,Ion-Exchange Chromatography,Chromatographies, Ion Exchange,Chromatographies, Ion-Exchange,Ion Exchange Chromatographies,Ion Exchange Chromatography,Ion-Exchange Chromatographies

Related Publications

T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui
January 1988, Anticancer research,
T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui
January 1987, Cancer investigation,
T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui
August 1984, Biochemical and biophysical research communications,
T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui
December 2004, Nihon rinsho. Japanese journal of clinical medicine,
T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui
October 2005, Clinical biochemistry,
T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui
March 1971, International journal of cancer,
T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui
December 1986, Biochemical medicine and metabolic biology,
T Tanaka, and M Kobayashi, and O Saito, and N Kamada, and A Kuramoto, and T Usui
January 1981, Leukemia research,
Copied contents to your clipboard!